These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 12919287
1. Structural and functional characteristics of a dominant-negative isoform of porcine MHC class II transactivator. Quinn G, Bower R, Dos-Santos Cruz G, Giovino M, Xu Y, Patience C, Schuurman HJ. Eur J Immunogenet; 2003 Aug; 30(4):259-70. PubMed ID: 12919287 [Abstract] [Full Text] [Related]
2. Suppression of human anti-porcine T-cell immune responses by major histocompatibility complex class II transactivator constructs lacking the amino terminal domain. Yun S, Gustafsson K, Fabre JW. Transplantation; 1998 Jul 15; 66(1):103-11. PubMed ID: 9679829 [Abstract] [Full Text] [Related]
4. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins. Broxmeyer HE, Cooper S, Hangoc G, Chang CH. Exp Hematol; 2006 Aug 15; 34(8):1078-84. PubMed ID: 16863914 [Abstract] [Full Text] [Related]
7. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene. Rohn W, Tang LP, Dong Y, Benveniste EN. J Immunol; 1999 Jan 15; 162(2):886-96. PubMed ID: 9916712 [Abstract] [Full Text] [Related]
8. IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha. Giroux M, Schmidt M, Descoteaux A. J Immunol; 2003 Oct 15; 171(8):4187-94. PubMed ID: 14530341 [Abstract] [Full Text] [Related]
9. Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein. Montani V, Taniguchi SI, Shong M, Suzuki K, Ohmori M, Giuliani C, Napolitano G, Saji M, Fiorentino B, Reimold AM, Ting JP, Kohn LD, Singer DS. Endocrinology; 1998 Jan 15; 139(1):280-9. PubMed ID: 9421426 [Abstract] [Full Text] [Related]
10. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B. Science; 1994 Jul 01; 265(5168):106-9. PubMed ID: 8016643 [Abstract] [Full Text] [Related]
12. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma. Piskurich JF, Gilbert CA, Ashley BD, Zhao M, Chen H, Wu J, Bolick SC, Wright KL. Mol Immunol; 2006 Feb 01; 43(6):519-28. PubMed ID: 15950283 [Abstract] [Full Text] [Related]
14. Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells. Butticè G, Miller J, Wang L, Smith BD. Circ Res; 2006 Mar 03; 98(4):472-9. PubMed ID: 16439692 [Abstract] [Full Text] [Related]
15. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts. Holtz R, Choi JC, Petroff MG, Piskurich JF, Murphy SP. Biol Reprod; 2003 Sep 03; 69(3):915-24. PubMed ID: 12748124 [Abstract] [Full Text] [Related]
17. RB and a novel E2F-1 binding protein in MHC class II deficient B-cell lines and normal IFN-gamma induction of the class IL transactivator CIITA in class II non-inducible RB-defective tumor lines. Tschickardt ME, Lu Y, Jacim M, Ussery GD, Steimle V, Mach B, Blanck G. Int J Cancer; 1995 Aug 09; 62(4):461-5. PubMed ID: 7635572 [Abstract] [Full Text] [Related]
18. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction. Chin KC, Mao C, Skinner C, Riley JL, Wright KL, Moreno CS, Stark GR, Boss JM, Ting JP. Immunity; 1994 Nov 09; 1(8):687-97. PubMed ID: 7600294 [Abstract] [Full Text] [Related]
19. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Chang CH, Guerder S, Hong SC, van Ewijk W, Flavell RA. Immunity; 1996 Feb 09; 4(2):167-78. PubMed ID: 8624807 [Abstract] [Full Text] [Related]